RJA
FXH icon

Raymond James & Associates’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Raymond James & Associates’s Portfolio FXH Stock Details FXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$17.6M Sell
156,913
-7,060
-4% -$773K 0.01% 897
2024
Q2 		$17.1M Sell
163,973
-6,102
-4% -$641K 0.01% 856
2024
Q1 		$18.6M Sell
170,075
-4,593
-3% -$485K 0.01% 813
2023
Q4 		$18.1M Sell
174,668
-31,625
-15% -$3.05M 0.01% 783
2023
Q3 		$20M Sell
206,293
-6,384
-3% -$662K 0.02% 681
2023
Q2 		$23M Sell
212,677
-16,942
-7% -$1.81M 0.02% 635
2023
Q1 		$24.7M Buy
229,619
+412
+0.2% +$44.8K 0.02% 602
2022
Q4 		$24.9M Buy
229,207
+37,253
+19% +$3.91M 0.02% 579
2022
Q3 		$18.7M Sell
191,954
-7,647
-4% -$805K 0.02% 637
2022
Q2 		$20.6M Buy
199,601
+3,900
+2% +$420K 0.02% 604
2022
Q1 		$22.4M Sell
195,701
-19,407
-9% -$2.18M 0.02% 641
2021
Q4 		$26.7M Sell
215,108
-2,793
-1% -$334K 0.02% 605
2021
Q3 		$25.9M Sell
217,901
-5,069
-2% -$620K 0.02% 577
2021
Q2 		$26.1M Buy
222,970
+11,043
+5% +$1.26M 0.02% 575
2021
Q1 		$23M Buy
211,927
+12,008
+6% +$1.31M 0.02% 603
2020
Q4 		$21.5M Sell
199,919
-47,699
-19% -$4.85M 0.02% 584
2020
Q3 		$23.5M Sell
247,618
-51,356
-17% -$4.81M 0.03% 477
2020
Q2 		$27M Sell
298,974
-29,728
-9% -$2.55M 0.04% 410
2020
Q1 		$24.3M Buy
328,702
+50,342
+18% +$4.09M 0.04% 386
2019
Q4 		$23.4M Sell
278,360
-26,390
-9% -$2.09M 0.03% 513
2019
Q3 		$22.6M Sell
304,750
-84,546
-22% -$6.45M 0.03% 499
2019
Q2 		$30.2M Sell
389,296
-197,082
-34% -$14.6M 0.04% 402
2019
Q1 		$44.8M Buy
586,378
+63,224
+12% +$4.72M 0.07% 272
2018
Q4 		$36M Buy
523,154
+242,767
+87% +$18.4M 0.06% 287
2018
Q3 		$23.8M Buy
280,387
+26,328
+10% +$2.1M 0.04% 467
2018
Q2 		$18.9M Buy
254,059
+46,646
+22% +$3.37M 0.03% 529
2018
Q1 		$14.4M Sell
207,413
-49,469
-19% -$3.57M 0.03% 595
2017
Q4 		$17.9M Sell
256,882
-15,315
-6% -$1.05M 0.03% 516
2017
Q3 		$18.4M Buy
272,197
+21,115
+8% +$1.41M 0.04% 488
2017
Q2 		$16.8M Buy
251,082
+74,872
+42% +$4.81M 0.04% 495
2017
Q1 		$11M Buy
176,210
+134
+0.1% +$8.18K 0.03% 615
2016
Q4 		$10.1M Sell
176,076
-12,266
-7% -$710K 0.03% 628
2016
Q3 		$11.5M Sell
188,342
-7,801
-4% -$474K 0.03% 542
2016
Q2 		$11.6M Sell
196,143
-154,079
-44% -$8.93M 0.04% 486
2016
Q1 		$19.5M Sell
350,222
-637,731
-65% -$34.5M 0.07% 315
2015
Q4 		$59.7M Buy
987,953
+106,674
+12% +$6.37M 0.21% 98
2015
Q3 		$51.3M Buy
881,279
+54,903
+7% +$3.64M 0.21% 99
2015
Q2 		$56.9M Buy
826,376
+171,374
+26% +$11.6M 0.22% 91
2015
Q1 		$43.9M Buy
655,002
+80,435
+14% +$5.13M 0.19% 104
2014
Q4 		$34.6M Buy
574,567
+45,135
+9% +$2.63M 0.17% 116
2014
Q3 		$29.5M Sell
529,432
-9,770
-2% -$536K 0.17% 111
2014
Q2 		$28.7M Sell
539,202
-11,381
-2% -$578K 0.18% 106
2014
Q1 		$28M Buy
550,583
+34,363
+7% +$1.75M 0.19% 92
2013
Q4 		$24.8M Buy
516,220
+110,298
+27% +$5.04M 0.19% 104
2013
Q3 		$17.6M Buy
405,922
+46,742
+13% +$1.97M 0.15% 133
2013
Q2 		$14.3M Buy
+359,180
New +$14.1M 0.13% 154

Other funds holding FXH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCH
PGIM Custom Harvest Newark, New Jersey $6.4B AUM 18.53% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Raymond James & Associates's FXH Position: Q3 2024 in Review

Raymond James & Associates reduced its First Trust Health Care AlphaDEX Fund (FXH) stake by 4.3% in Q3 2024, selling an estimated $773K and leaving 156,913 shares worth $17.6M. The position accounts for 0.01% of the portfolio, ranked #897.

Raymond James & Associates first reported a position in FXH in Q2 2013 and has held it in 46 quarters since. The position peaked at $59.7M in Q4 2015. 254 funds tracked by Wall St. Rank hold FXH as of Q3 2024.

  • Raymond James & Associates held 156,913 shares of First Trust Health Care AlphaDEX Fund worth $17.6M as of Q3 2024.
  • Raymond James & Associates sold 7,060 First Trust Health Care AlphaDEX Fund shares in Q3 2024, an estimated $773K.
  • First Trust Health Care AlphaDEX Fund made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #897 holding.
  • Raymond James & Associates first reported a position in First Trust Health Care AlphaDEX Fund in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's First Trust Health Care AlphaDEX Fund position peaked at $59.7M in Q4 2015.
  • 254 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.